About Jan Ohrstrom
Form D filings for Blaze Bioscience from 2015 to 2024 list Jan Ohrstrom as director.
Jan Ohrstrom reports to the SEC as a director or officer of 2 public companies: Avigen (AVGN) and Zymogenetics (ZGEN).
Jan Ohrstrom first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Jan Ohrstrom in the role, so the role may have started earlier or lasted longer.
AI
Avigen Inc.
Director
2007 – 2009 · Public company (AVGN)
ZI
Zymogenetics Inc.
Sr. VP, Business Development
2006 – 2007 · Public company (ZGEN)
Key Colleagues at Startups
The people Jan Ohrstrom works with at each company, as listed on that company's latest Form D.
Blaze Bioscience, Inc. · Form D, Oct 21, 2024
HF
Heather Franklin
Director
LL
Ludmila Lobanova
Executive officer
SD
Steven Daly
Chief Executive Officer and director
JT
James Towne
Executive officer and director
LH
Lawrence Hughes
Director